• Thurs news: Lilly’s weight-loss drug prevents diabetes. Merck pays $588M for bispecific. Amgen speaks out about bone density issues with obesity drug. PTC gets gene therapy approval. JNJ’s 340B legal fight. See more on our front page
Replies
5
Views
854
Replies
18
Views
2K
Replies
9
Views
212
Replies
84
Views
10K
Replies
25
Views
2K
Replies
4
Views
568
Replies
3
Views
457